RecruitingNCT01793168
1
studies recruiting now
as of 7 Sept 2026
1
studies registered in total
as of 7 Sept 2026
2
countries with a recruiting site
as of 7 Sept 2026
15 Feb 2013
most recent study posted
among recruiting studies
Recruiting trials
Showing the 1 most recently updated recruiting study, as recorded 7 Sept 2026. Live status on each study page.
Search all Early-onset partial cataract studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Early-onset partial cataract study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Early-onset partial cataract
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
8 approved treatments and 33 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Nepafenac (Ilevro)Approved: Ketorolac Tromethamine (Acular)Approved: Diclofenac (Voltaren ophthalmic)Approved: Carbachol (Carbachol)Approved: Tirilazad MesylateApproved: Acetylcholine Chloride (Miochol)Approved: Bromfenac Sodium (Bromday)Approved: Acetylcholine
Phase 3Dexamethasone (Aeroseb-dex)
Phase 3Chloroprocaine
Phase 3Levofloxacin (Evoxil)
Phase 3Loteprednol Etabonate (Alrex)
Phase 3Ketorolac
Phase 3Bromfenac
Phase 3Ascorbic Acid (Ascor)
Phase 3Tobramycin (Aktob)
+ 25 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).